Compare · PHR vs RELX
PHR vs RELX
Side-by-side comparison of Phreesia Inc. (PHR) and RELX PLC PLC (RELX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PHR and RELX operate in Real Estate (Real Estate), so they compete in similar markets.
- RELX is the larger of the two at $66.74B, about 119.3x PHR ($559.6M).
- Over the past year, PHR is down 61.9% and RELX is down 32.1% - RELX leads by 29.9 points.
- PHR has been more active in the news (23 items in the past 4 weeks vs 9 for RELX).
- PHR has more recent analyst coverage (25 ratings vs 10 for RELX).
- Company
- Phreesia Inc.
- RELX PLC PLC
- Price
- $9.60+4.35%
- $36.72+0.34%
- Market cap
- $559.6M
- $66.74B
- 1M return
- +14.29%
- +10.45%
- 1Y return
- -61.93%
- -32.06%
- Industry
- Real Estate
- Real Estate
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- 2015
- News (4w)
- 23
- 9
- Recent ratings
- 25
- 10
Phreesia Inc.
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a Web-based dashboard for providers; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; appointments solution for online appointments, reminders, and referral tracking; and patient activation solution that enables providers to communicate with their patients through surveys, announcements, messaging, and health campaigns. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and PRO data for approximately 25 specialties; and life sciences solution to deliver targeted and clinically relevant marketing content to patients, as well as COVID-19 product offerings for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was founded in 2005 and is headquartered in Raleigh, North Carolina.
RELX PLC PLC
RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Scientific, Technical & Medical; Risk; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as enhance the productivity. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.
Latest PHR
- Phreesia Sets Release Date for Fiscal First Quarter 2027 Results
- SEC Form 4 filed by Hui Yvonne
- SEC Form 4 filed by Hoffman Allison C
- SEC Form 4 filed by Linetsky David
- SEC Form 4 filed by Hui Yvonne
- Phreesia Named to Becker's Hospital Review's 2026 List of "Revenue Cycle Management Companies to Know"
- SEC Form 4 filed by Gandhi Balaji
- SEC Form 4 filed by Hoffman Allison C
- SEC Form 4 filed by Indig Chaim
- SEC Form 4 filed by Hui Yvonne
Latest RELX
- SEC Form 6-K filed by RELX PLC PLC
- WEPACK 2026 Concludes on a Record High, Reinforcing China's Role at the Heart of the Global Packaging Industry
- SEC Form 6-K filed by RELX PLC PLC
- Cytora and LexisNexis Risk Solutions announce strategic relationship to enhance risk selection and automation for U.S. commercial insurers
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- LexisNexis Risk Solutions Builds on Agenium Alliance with Expanded Medical Data Access for Life Insurers
- Synthetic Identities and Agentic Bots Posing as Human Contribute to 8% Global Rise in Fraud Attacks - LexisNexis Risk Solutions
- RELX upgraded by Citigroup
- SEC Form 6-K filed by RELX PLC PLC